Randomised controlled trials may underestimate drug effects: Balanced placebo trial design

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Lund, Karen ^a   Vase, Lene ^b   Petersen, Gitte L ^b   Jensen, Troels S ^a   Finnerup, Nanna B ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; LIDOCAINE; PLACEBO; SODIUM CHLORIDE;

ADULT; ANALGESIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; EFFECT SIZE; EXPERIMENTAL PAIN; EXPERIMENTAL STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; JAW MUSCLE; MALE; MASSETER MUSCLE; MYALGIA; NORMAL HUMAN; PAIN ASSESSMENT; PLACEBO EFFECT; RANDOMIZED CONTROLLED TRIAL (TOPIC); STUDY DESIGN; TREATMENT OUTCOME; TREATMENT RESPONSE;

FEMALE; HUMANS; LIDOCAINE; MALE; PAIN; PLACEBOS; SALINE SOLUTION, HYPERTONIC; YOUNG ADULT;

EID: 84897460691     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084104     Document Type: Article

References (36)

1. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS (1996) Evidence based medicine: what it is and what it isn't. BMJ 312: 71-72.
2. Enck P, Klosterhalfen S, Weimer K, Horing B, Zipfel S (2011) The placebo response in clinical trials: more questions than answers. Philos Trans R Soc Lond B Biol Sci 366: 1889-1895.
3. Kirsch I (2000) Are drug and placebo effects in depression additive? Biol Psychiatry 47: 733-735.
4. Walach H, Falkenberg T, Fonnebo V, Lewith G, Jonas WB (2006) Circular instead of hierarchical: methodological principles for the evaluation of complex interventions. BMC Med Res Methodol: 29.
5. Meissner K, Kohls N, Colloca L (2011) Introduction to placebo effects in medicine: mechanisms and clinical implications. Philos Trans R Soc Lond B Biol Sci 366: 1783-1789.
6. Fountoulakis KN, Moller HJ (2012) Antidepressant drugs and the response in the placebo group: the real problem lies in our understanding of the issue. J Psychopharmacol 26: 744-750.
7. Katz J, Finnerup NB, Dworkin RH (2008) Clinical trial outcome in neuropathic pain: relationship to study characteristics. Neurology 70: 263-272. (Pubitemid 351156805)
8. Moerman DE (2000) Cultural variations in the placebo effect: ulcers, anxiety, and blood pressure. Med Anthropol Q 14: 51-72.
9. Finnerup NB, Sindrup SH, Jensen TS (2010) The evidence for pharmacological treatment of neuropathic pain. Pain 150: 573-581.
10. Khan A, Detke M, Khan SR, Mallinckrodt C (2003) Placebo response and antidepressant clinical trial outcome. J Nerv Ment Dis 191: 211-218. (Pubitemid 36522920)
11. Eccles R (2010) Importance of placebo effect in cough clinical trials. Lung 188 Suppl 1: S53-S61.
12. Bridge JA, Birmaher B, Iyengar S, Barbe RP, Brent DA (2009) Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder. Am J Psychiatry 166: 42-49.
13. van Die MD, Bone KM, Burger HG, Teede HJ (2009) Are we drawing the right conclusions from randomised placebo-controlled trials? A post-hoc analysis of data from a randomised controlled trial. BMC Med Res Methodol: 9.
14. Leuchter AF, Cook IA, Witte EA, Morgan M, Abrams M (2002) Changes in brain function of depressed subjects during treatment with placebo. Am J Psychiatry 159: 122-129. (Pubitemid 41070737)
15. Petrovic P, Kalso E, Petersson KM, Andersson J, Fransson P, et al. (2010) A prefrontal non-opioid mechanism in placebo analgesia. Pain 150: 59-65.
16. Dworkin RH, Turk DC, Peirce-Sandner S, Burke LB, Farrar JT, et al. (2012) Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations. Pain 153: 1148-1158.
17. Kirsch I, Moore TJ, Scoboria A, Nicholls SS (2002) The emperor's new drugs: An analysis of Antidepressant Medication data submitted to the U.S. Food and Drug Administration. Prevention and treatment 5: Article 23.
18. Waring DR (2008) The antidepressant debate and the balanced placebo trial design: an ethical analysis. Int J Law Psychiatry 31: 453-462.
19. Kirsch I (2013) The placebo effect revisited: Lessons learned to date. Complement Ther Med 21: 102-104.
20. Benedetti F, Carlino E, Pollo A (2011) How placebos change the patient's brain. Neuropsychopharmacology 36: 339-354.
21. Rohsenow DJ, Marlatt GA (1981) The balanced placebo design: methodological considerations. Addict Behav 6: 107-122. (Pubitemid 11050255)
22. Bendixen KH, Baad-Hansen L, Cairns BE, Svensson P (2010) Effects of low-dose intramuscular ketorolac on experimental pain in the masseter muscle of healthy women. J Orofac Pain 24: 398-407.
23. Horjales-Araujo E, Finnerup NB, Jensen TS, Svensson P (2013) Differential effect of visual and gustatory stimuli on experimental jaw muscle pain. Eur J Pain 17: 811-819.
24. Ross S, Krugman AD, Lyerly SB, Clyde DJ (1962) Drugs and placebos: A model design. Psychological reports 10: 383-392.
25. Amanzio M, Benedetti F (1999) Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems. J Neurosci 19: 484-494. (Pubitemid 29028987)
26. Vase L, Riley JL III, Price DD (2002) A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia. Pain 99: 443-452. (Pubitemid 35284275)
27. Vase L, Robinson ME, Verne GN, Price DD (2005) Increased placebo analgesia over time in irritable bowel syndrome (IBS) patients is associated with desire and expectation but not endogenous opioid mechanisms. Pain 115: 338-347. (Pubitemid 40725290)
28. Mora MS, Nestoriuc Y, Rief W (2011) Lessons learned from placebo groups in antidepressant trials. Philos Trans R Soc Lond B Biol Sci 366: 1879-1888.
29. Cepeda MS, Berlin JA, Gao CY, Wiegand F, Wada DR (2012) Placebo response changes depending on the neuropathic pain syndrome: results of a systematic review and meta-analysis. Pain Med 13: 575-595.
30. Hammami MM, Al-Gaai EA, Alvi S, Hammami MB (2010) Interaction between drug and placebo effects: a cross-over balanced placebo design trial. Trials 11: 1-10.
31. Finniss DG, Kaptchuk TJ, Miller F, Benedetti F (2010) Biological, clinical, and ethical advances of placebo effects. Lancet 375: 686-695.
32. Turner JA, Jensen MP, Warms CA, Cardenas DD (2002) Blinding effectiveness and association of pretreatment expectations with pain improvement in a double-blind randomized controlled trial. Pain 99: 91-99. (Pubitemid 35247533)
33. Moncrieff J, Wessely S, Hardy R (2004) Active placebos versus antidepressants for depression. Cochrane Database Syst Rev CD003012.
34. Rief W, Glombiewski JA (2012) The hidden effects of blinded, placebo-controlled randomized trials: an experimental investigation. Pain 153: 2473-2477.
35. Enck P, Klosterhalfen S, Zipfel S (2011) Novel study designs to investigate the placebo response. BMC Med Res Methodol 11: 90-11.
36. Enck P, Bingel U, Schedlowski M, Rief W (2013) The placebo response in medicine: minimize, maximize or personalize? Nat Rev Drug Discov 12: 191-204.